| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Memorial Sloan-Kettering Cancer Center serves as a 10% Owner at ATNM. Across recent SEC filings that breaks down to 0 buys and 120 sells. Those positions are worth an estimated $8.7M at current prices.
The biggest single holding is ATNM (~$8.7M) as 10% Owner. The recent filings there lean toward selling, a net 992,826 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2016 | ATNM Actinium Pharmaceuticals, Inc. | 10% Owner | Sell | 192,927 | $1.83 | $352,372.39 | -3.9% | |
| Aug 29, 2016 | ATNM Actinium Pharmaceuticals, Inc. | 10% Owner | Sell | 50,000 | $1.71 | $85,495.02 | -1.0% | |
| Aug 16, 2016 | ATNM Actinium Pharmaceuticals, Inc. | 10% Owner | Sell | 9,468 | $1.72 | $16,286.96 | -0.2% | |
| Jul 12, 2016 | ATNM Actinium Pharmaceuticals, Inc. | 10% Owner | Sell | 3,100 | $1.80 | $5,581.00 | - | |
| Jul 11, 2016 | ATNM Actinium Pharmaceuticals, Inc. | 10% Owner | Sell | 21,990 | $1.80 | $39,582.00 | -0.4% | |
| Jul 6, 2016 | ATNM Actinium Pharmaceuticals, Inc. | 10% Owner | Sell | 20,840 | $1.81 | $37,762.20 | -0.4% | |
| Jul 1, 2016 | ATNM Actinium Pharmaceuticals, Inc. | 10% Owner | Sell | 151,150 | $1.81 | $273,991.48 | -2.9% | |
| Jun 15, 2016 | ATNM Actinium Pharmaceuticals, Inc. | 10% Owner | Sell | 33,619 | $1.90 | $63,876.10 | -0.6% | |
| Jun 2, 2016 | ATNM Actinium Pharmaceuticals, Inc. | 10% Owner | Sell | 17,790 | $2.01 | $35,715.80 | -0.3% | |
| Jun 1, 2016 | ATNM Actinium Pharmaceuticals, Inc. | 10% Owner | Sell | 169,450 | $1.97 | $333,384.51 | -3.2% |